Hai Gang Chen
Direttore/Membro del Consiglio presso SINOMAB BIOSCIENCE LIMITED
Profilo
Hai Gang Chen is currently a Non-Executive Director at Sinomab Bioscience Ltd., a Director at Bellen Chemistry Co., Ltd., a Director at Yatra Pharmaceutical Technology (Shanghai) Co., Ltd., an Investment Director at Shanghai Yueyi Investment Center, a Director at Shanghai Weishen Pharmaceutical Co., Ltd., a Co-General Partner at Shanghai Xingze Xinghe Investment Management Center, and a Member-Supervisory Board at Suzhou Sinovent Pharmaceutical Technology Co. Ltd.
Previously, he worked as a Senior Manager at CITIC Securities Co., Ltd.
from 2010 to 2011 and as an Analyst at China International Capital Corp.
Ltd.
(Broker).
He holds a doctorate degree from Peking Union Medical College, conferred in 2009.
Posizioni attive di Hai Gang Chen
Società | Posizione | Inizio |
---|---|---|
SINOMAB BIOSCIENCE LIMITED | Direttore/Membro del Consiglio | 01/08/2017 |
Shanghai Yueyi Investment Center | Direttore degli Investimenti | - |
Shanghai Xingze Xinghe Investment Management Center | Corporate Officer/Principal | 01/09/2016 |
Suzhou Sinovent Pharmaceutical Technology Co. Ltd.
Suzhou Sinovent Pharmaceutical Technology Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Sinovent Pharmaceutical Technology Co. Ltd. is a private company that focuses on researching, developing, producing, and commercializing therapeutic drugs. The company is based in Suzhou, China. | Direttore/Membro del Consiglio | - |
Shanghai Weishen Pharmaceutical Co., Ltd.
Shanghai Weishen Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Shanghai Weishen Pharmaceutical Co., Ltd. is a company founded in 2019 that specializes in the research, development, production, sale, and service of pharmaceutical machinery. The company is based in Shanghai, China. The Chinese company focuses on scientific and technological innovation to serve the pharmaceutical industry with advanced technology. The company has a professional installation team with a minimum of 6 years of experience, possessing strong practical hands-on problem-solving capabilities. The company aims to improve the production standard and maximize investment benefits through effective training. | Direttore/Membro del Consiglio | - |
Bellen Chemistry Co., Ltd.
Bellen Chemistry Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Bellen Chemistry Co., Ltd. provides contract chemistry services. It offers chemical synthesis contract development and manufacturing organization (CDMO) services, chemical synthesis contract research organization (CRO) services, and drug molecular building blocks. The company was founded by Bo Liu, Li Xin Xing, Jian Hua Ren, Jian Xun Liu, and Yong Jun Jiang on January 28, 2010 and is headquartered in Beijing, China. | Direttore/Membro del Consiglio | 01/01/2019 |
Yatra Pharmaceutical Technology (Shanghai) Co., Ltd.
Yatra Pharmaceutical Technology (Shanghai) Co., Ltd. BiotechnologyHealth Technology Part of Hepagene Therapeutics, Inc., Yatra Pharmaceutical Technology (Shanghai) Co., Ltd. is a Chinese company that engages in research and development of new drugs. The company is based in Shanghai, China. The company was founded in 2016 by Xiao Dong Xu. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Hai Gang Chen
Società | Posizione | Fine |
---|---|---|
CITIC SECURITIES COMPANY LIMITED | Corporate Officer/Principal | 01/04/2011 |
China International Capital Corp. Ltd. (Broker)
China International Capital Corp. Ltd. (Broker) Investment Banks/BrokersFinance China International Capital Corp. Ltd. (Broker) (CICC) is the brokerage division of China International Capital Corp. Ltd. which was established in 1995 as a strategic partnership between Chinese and international financial institutions and corporations. Headquartered in Beijing, CICC was the first joint venture investment bank in China. The firm's core business departments were investment banking, capital markets, sales & trading, research, fixed-income and asset management. CICC offers a range of brokerage services to international and domestic institutional and individual investors. In 2007 the firm set up a wholly-owned subsidiary specializing in private equity investments and focusing on buyout opportunities within China. | Analyst-Equity | - |
Formazione di Hai Gang Chen
Peking Union Medical College | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
SINOMAB BIOSCIENCE LIMITED | Health Technology |
CITIC SECURITIES COMPANY LIMITED | Finance |
Aziende private | 7 |
---|---|
China International Capital Corp. Ltd. (Broker)
China International Capital Corp. Ltd. (Broker) Investment Banks/BrokersFinance China International Capital Corp. Ltd. (Broker) (CICC) is the brokerage division of China International Capital Corp. Ltd. which was established in 1995 as a strategic partnership between Chinese and international financial institutions and corporations. Headquartered in Beijing, CICC was the first joint venture investment bank in China. The firm's core business departments were investment banking, capital markets, sales & trading, research, fixed-income and asset management. CICC offers a range of brokerage services to international and domestic institutional and individual investors. In 2007 the firm set up a wholly-owned subsidiary specializing in private equity investments and focusing on buyout opportunities within China. | Finance |
Shanghai Yueyi Investment Center | |
Shanghai Xingze Xinghe Investment Management Center | |
Suzhou Sinovent Pharmaceutical Technology Co. Ltd.
Suzhou Sinovent Pharmaceutical Technology Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Sinovent Pharmaceutical Technology Co. Ltd. is a private company that focuses on researching, developing, producing, and commercializing therapeutic drugs. The company is based in Suzhou, China. | Commercial Services |
Shanghai Weishen Pharmaceutical Co., Ltd.
Shanghai Weishen Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Shanghai Weishen Pharmaceutical Co., Ltd. is a company founded in 2019 that specializes in the research, development, production, sale, and service of pharmaceutical machinery. The company is based in Shanghai, China. The Chinese company focuses on scientific and technological innovation to serve the pharmaceutical industry with advanced technology. The company has a professional installation team with a minimum of 6 years of experience, possessing strong practical hands-on problem-solving capabilities. The company aims to improve the production standard and maximize investment benefits through effective training. | Health Technology |
Bellen Chemistry Co., Ltd.
Bellen Chemistry Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Bellen Chemistry Co., Ltd. provides contract chemistry services. It offers chemical synthesis contract development and manufacturing organization (CDMO) services, chemical synthesis contract research organization (CRO) services, and drug molecular building blocks. The company was founded by Bo Liu, Li Xin Xing, Jian Hua Ren, Jian Xun Liu, and Yong Jun Jiang on January 28, 2010 and is headquartered in Beijing, China. | Commercial Services |
Yatra Pharmaceutical Technology (Shanghai) Co., Ltd.
Yatra Pharmaceutical Technology (Shanghai) Co., Ltd. BiotechnologyHealth Technology Part of Hepagene Therapeutics, Inc., Yatra Pharmaceutical Technology (Shanghai) Co., Ltd. is a Chinese company that engages in research and development of new drugs. The company is based in Shanghai, China. The company was founded in 2016 by Xiao Dong Xu. | Health Technology |
- Borsa valori
- Insiders
- Hai Gang Chen